FDA Okays New Pill To Treat Certain Patients With Non-small Cell Lung Cancer

… EGFR T790M mutation-positive non-small cell lung cancer or NSCLC, as detected by … in patients with non-small cell lung cancer, including T790M. The FDA approval … response was 12.4 months. Lung cancer is the leading cause of … , prostate and colorectal cancers combined. Lung cancer has a five-year survival rate …